Genetic Characterization of Multidrug-Resistant Bacteria and
Antibacterial Activity of Alpha-Mangostin and Clove Oil
Nanostructured Lipid Carriers in Canine Periodontitis
1Center
of Excellence in Wildlife, Exotic, and Aquatic Animal Pathology,
Faculty of Veterinary Science, Chulalongkorn University, Bangkok
10330, Thailand; 2Center of Excellence in Systems
Microbiology (CESM), Department of Biochemistry, Faculty of
Medicine, Chulalongkorn University, Bangkok, 10330, Thailand; 3National
Nanotechnology Center (NANOTEC), National Science and Technology
Development Agency (NSTDA), Pathumthani 12120, Thailand; 4Department
of Veterinary Surgery, Faculty of Veterinary Science, Chulalongkorn
University, Bangkok, Thailand; 5Center of Excellence for
Companion Animal Cancer, Faculty of Veterinary Science,
Chulalongkorn University, Bangkok, Thailand;
6INSERM
UMR1163, Imagine Institute, Universite Paris Cite, Paris 75015,
France.
Canine periodontitis is a prevalent oral disease increasingly complicated by
multidrug-resistant (MDR) bacteria, reducing the effectiveness of current
antimicrobial therapies and creating treatment challenges. This study evaluated
the antimicrobial efficacy of a nanostructured lipid carrier loaded with alpha-mangostin
and clove oil (NLC-AMCO) against MDR oral bacteria. Forty-nine bacterial strains
were isolated and characterized from thirty dogs diagnosed with clinical
periodontitis. Antibacterial activity was assessed using standard phenotypic
assays, including disc diffusion, minimum inhibitory concentration (MIC),
minimum bactericidal concentration (MBC), and total plate count (TPC), while
whole genome sequencing (WGS) was applied to identify resistance gene profiles.
NLC-AMCO demonstrated superior antimicrobial efficacy compared to alpha-mangostin
and clove oil (AMCO) and commonly used antibiotics (amoxicillin, clindamycin,
doxycycline, and metronidazole), exhibiting broader inhibition zones (up to
24-30 mm) and rapid bactericidal activity within 30 min. Time-dependent
improvements in MIC and MBC values confirmed the sustained-release capability of
the NLC-AMCO. At 48 h, MICs were reduced by half for key MDR isolates, including
Escherichia coli_CU1 (31.25 to 15.62mg/mL),
Morganella morganii_CU1 (15.62 to 7.8mg/mL), and
Acinetobacter baumannii (3.9 to 1.95mg/mL), with comparable decreases
in MBC values. WGS analysis revealed extensive resistomes, particularly
in Pseudomonasaeruginosa and E.coli, carrying
genes resistant to
fluoroquinolones and last-resort agents such as colistin. These findings
highlight the potential of NLC-AMCO as a plant-based nano-formulation for
improving veterinary dental care in dogs with MDR infections and support its
relevance for future antimicrobial-stewardship strategies in companion-animal
medicine.
To Cite This Article:
Sawatphakdee G, Payungporn S, Chanchaem P, Yostawonkul J, Kamble MT, Tabtieang
SP, Nowwarote N, and Pirarat N,
2026. Genetic characterization of
multidrug-resistant bacteria and antibacterial activity of alpha-mangostin and
clove oil nanostructured lipid carriers in canine periodontitis. Pak Vet
J, 46(3): 681-690. http://dx.doi.org/10.29261/pakvetj/2026.057